Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to AML
Related studies linked through entity extraction aliases.
Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias
- Status
- TERMINATED
- Phase
- PHASE1
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of APVO436 in Patients With AML or MDS
- Status
- UNKNOWN
- Phase
- PHASE1
Using Sorafenib as a Salvage Treatment for Relapsed or Refractory Acute Myeloid Leukemia Carrying FLT3-ITD
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Evaluation of IM23 CAR-T Cells (IM23CAR-T)
- Status
- COMPLETED
- Phase
- PHASE1
Italian Non-Interventional Study of FLT3 Mutated AML Patients
- Status
- UNKNOWN
- Phase
- N/A
Ascorbic Acid Levels in MDS, AML, and CMML Patients
- Status
- COMPLETED
- Phase
- N/A
Epacadostat, Cladribine and Cytarabine (ECC) in AML
- Status
- WITHDRAWN
- Phase
- PHASE1
DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Pevonedistat and Low Dose Cytarabine in Adult Patients With AML and MDS
- Status
- COMPLETED
- Phase
- PHASE1
Epacadostat, Idarubicin and Cytarabine (EIC) in AML
- Status
- WITHDRAWN
- Phase
- PHASE1
Individual Patient Expanded Access Gilteritinib (ASP2215)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Haploidentical Donor vs mMUD in Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Combination of Sorafenib and Omacetaxine Mepesuccinate in Newly Diagnosed or Relapsed/Refractory AML Carrying FLT3-ITD
- Status
- COMPLETED
- Phase
- PHASE2
iCare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AML
- Status
- WITHDRAWN
- Phase
- N/A
Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD
- Status
- UNKNOWN
- Phase
- PHASE2
Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2